statview statistics package (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
statview statistics package
Statview Statistics Package, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+package+statview/statview+5+0/pmc12267275-126-6-9
Average 90 stars, based on 1 article reviews
Statview Statistics Package, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+package+statview/statview+5+0/pmc12267275-126-6-9
Average 90 stars, based on 1 article reviews
statview statistics package - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Vitamin D and Ceramide Metabolomic Profile in Acute Myocardial Infarction. Article Snippet: The statistical package Statview, version 5.0.1 (SAS Institute, Abacus Concept, Inc., Berkeley, CA, USA), was used to perform the analyses. Article Title: Potentially preventable antepartum stillbirths in a high-resource setting: a prospective audit-based study. Article Snippet: Objectives: The primary objective was the identification of sub-standard care in antepartum stillbirths in Emilia-Romagna Region (Italy), hence the number of potentially preventable cases.. Secondly, we seek to evaluate any association between inadequate care and either risk factors for stillbirth or causes of death.. Study Design: This study was based on prospectively-collected data in an institutional stillbirth audit project, involving all 29 hospital with a maternity unit in Emilia-Romagna Region. Article Title: Contemporary prescriptions pattern of different dose levonorgestrel-releasing intrauterine systems in an Italian service for family planning. Article Snippet: Objective: Current research informations fail to adequately inform about when levonorgestrel-releasing intrauterine system (LNG-IUS) 52mg is used instead of other lower dose LNG-IUSs (13.5 and 19.5mg) and other long-acting reversible contraceptives (LARCs) in clinical practice.. Methods: A retrospective cohort study was performed in a third-level Service for Family Planning of Modena University hospital about all the first modern contraceptives prescriptions in the whole year 2019 performed by the same group of physicians.. All women included underwent a detailed transvaginal ultrasound (TVUS) at prescription and a second evaluation within 3months when they were still using the prescribed method. Article Title: A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns. Article Snippet: Purpose: Progestin-only pills (POPs), compared to combined, are not associated with an increased risk of venous thromboembolism, but are associated with a poor cycle control. the aim of this study was to evaluate the impact of a new POP [4 mg drospirenone (DRsP) for 24 days with a 4-day hormone-free interval] on some coagulation markers (both procoagulant and fibrinolytic) and to describe its impact on bleeding patterns.. Materials and methods: this is a prospective trial, based on serum evaluation of following coagulation markers and tests: Factor (F) X, F Viii, F V, iNR, aPtt, Protein s and antithrombin iii. a ‘bleeding diary’ was used to categorise women as having (1) unscheduled bleeding, (2) scheduled bleeding and (3) amenorrhoea. thirty patients were followed for six 28-day intake cycles, with a follow-up at the end of the 3rd and 6th cycles.. Results: there was a significant decrease of F X (p = 0.03) (-5.7% at cycle 6). Article Title: Drospirenone 4 mg in a 24 + 4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics. Article Snippet: Statistical analysis was performed using the statistical Article Title: BRCA mutation carriers’ perceptions on postmenopausal hormone therapy: An Italian study Article Snippet: The statistical analysis was performed using the statistical Article Title: The use of a pill containing ethinylestradiol-norgestimate improves female sexuality despite the decrease in circulating androgens: a pilot study. Article Snippet: Purpose: to evaluate the initial impact of a combined oral contraceptive (CoC) containing norgestimate (nGm) on female sexuality and on circulating androgen levels in users.. Materials and methods: Six months modification in the mcCoy Female Sexuality Questionnaire (mFSQ) and testosterone (t) and dehydroepiandrosterone sulphate (dHEaS) serum levels in women starting a monophasic pill containing ethinyl-estradiol (EE) 35 μg and nGm 0.250 mg.. Results: the study was completed by 36 subjects. there was a significant increase in mFSQ during treatment (p < 0.0001) (and its domains with the exclusion of vaginal lubrication domain) with concomitant decreases in t (−4.45%, p < 0.0001) and dHEaS (−19.41%, p < 0.0001) serum levels. |